Colgate-Palmolive Company (CL) Key Metrics
CL valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $75.02B
- Enterprise value
- $74.99B
- P/E (TTM)
- 37.1 10-yr median 28.0
- Forward P/E
- 21.0
- PEG ratio
- 1.57
- Price / sales
- 3.6 10-yr median 3.7
- Price / book
- 290.3 10-yr median 106.2
- EV / EBITDA
- 19.5 10-yr median 17.5
- Dividend yield
- 2.25% $2.12 a year
- Beta
- 0.32
CL key metrics, 2016–2025
Fiscal year ended December 31, 2025 · U.S. dollarsCL valuation Price multiples at each fiscal year-end price.
CL returns How much profit the business earns on the capital it uses.
CL per-share figures Results divided by the shares outstanding at year-end.
CL financial health Debt, liquidity and how easily interest is covered.
CL efficiency & capital use Working capital cycle and where the cash goes.
CL valuation history
CL returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
CL debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
CL cash returned to shareholders
CL price vs earnings per share
CL key metrics
2016–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||
| Market capitalization | $64.09B | $74.77B | $66.10B | $66.09B | $72.39B | $73.48B | $59.28B | $51.96B | $66.98B | $58.79B |
| Enterprise value | $71.36B | $82.03B | $74.19B | $74.59B | $78.99B | $80.33B | $73.58B | $57.60B | $72.03B | $64.01B |
| P/E ratio | 30.1 | 25.9 | 28.7 | 37.0 | 33.4 | 27.3 | 25.0 | 21.7 | 33.1 | 24.1 |
| Price / sales | 3.1 | 3.7 | 3.4 | 3.7 | 4.2 | 4.5 | 3.8 | 3.3 | 4.3 | 3.9 |
| Price / book | 175.6 | 137.5 | 69.1 | 82.0 | 74.6 | 66.7 | 106.2 | 263.8 | 275.7 | — |
| Price / free cash flow | 17.6 | 21.1 | 21.7 | 35.5 | 26.2 | 22.2 | 21.2 | 19.8 | 26.8 | 23.1 |
| Price / operating cash flow | 15.3 | 18.2 | 17.6 | 25.9 | 21.8 | 19.8 | 18.9 | 17.0 | 21.9 | 18.7 |
| EV / sales | 3.5 | 4.1 | 3.8 | 4.2 | 4.5 | 4.9 | 4.7 | 3.7 | 4.7 | 4.2 |
| EV / EBITDA | 14.7 | 16.9 | 17.5 | 22.1 | 21.0 | 18.5 | 18.3 | 13.8 | 17.5 | 14.8 |
| EV / free cash flow | 19.6 | 23.1 | 24.4 | 40.1 | 28.6 | 24.3 | 26.3 | 22.0 | 28.8 | 25.1 |
| Earnings yield | 3.3% | 3.9% | 3.5% | 2.7% | 3.0% | 3.7% | 4.0% | 4.6% | 3.0% | 4.2% |
| Free cash flow yield | 5.7% | 4.7% | 4.6% | 2.8% | 3.8% | 4.5% | 4.7% | 5.0% | 3.7% | 4.3% |
| Dividend yield | 2.8% | 2.4% | 2.6% | 2.6% | 2.3% | 2.3% | 2.7% | 3.1% | 2.3% | 2.6% |
| Shareholder yield (dividends + buybacks) | 4.7% | 4.7% | 4.4% | 4.5% | 4.1% | 4.3% | 4.8% | 5.4% | 4.4% | 4.8% |
| Share price at fiscal year-end | $79.02 | $90.91 | $79.71 | $78.79 | $85.34 | $85.51 | $68.84 | $59.52 | $75.45 | $65.44 |
| Per share | ||||||||||
| Revenue per share | $25.13 | $24.44 | $23.46 | $21.42 | $20.54 | $19.17 | $18.22 | $17.81 | $17.41 | $16.91 |
| Earnings per share | $2.63 | $3.51 | $2.77 | $2.13 | $2.55 | $3.14 | $2.75 | $2.75 | $2.28 | $2.72 |
| Operating cash flow per share | $5.18 | $4.99 | $4.52 | $3.05 | $3.92 | $4.33 | $3.64 | $3.50 | $3.44 | $3.50 |
| Free cash flow per share | $4.48 | $4.31 | $3.67 | $2.22 | $3.25 | $3.85 | $3.25 | $3.00 | $2.82 | $2.84 |
| Cash per share | $1.59 | $1.53 | $1.16 | $0.92 | $0.98 | $1.03 | $1.03 | $0.83 | $1.73 | $1.46 |
| Book value per share | $0.45 | $0.66 | $1.15 | $0.96 | $1.14 | $1.28 | $0.65 | $0.23 | $0.27 | $0.02 |
| Tangible book value per share | −$5.29 | −$5.45 | −$5.23 | −$5.32 | −$5.63 | −$6.54 | −$6.52 | −$4.55 | −$3.74 | −$3.79 |
| Dividends per share | $2.25 | $2.18 | $2.11 | $2.02 | $1.98 | $1.92 | $1.87 | $1.82 | $1.72 | $1.68 |
| Capex per share | $0.70 | $0.68 | $0.85 | $0.83 | $0.67 | $0.48 | $0.39 | $0.50 | $0.62 | $0.66 |
| Debt per share | $10.55 | $10.35 | $10.93 | $11.05 | $8.76 | $9.01 | $17.63 | $7.29 | $7.41 | $7.27 |
| Shares outstanding | 811.1M | 822.5M | 829.2M | 838.8M | 848.3M | 859.3M | 861.1M | 873.0M | 887.8M | 898.4M |
| Change in shares outstanding | −1.4% | −0.8% | −1.1% | −1.1% | −1.3% | −0.2% | −1.4% | −1.7% | −1.2% | −1.2% |
| Returns & profitability | ||||||||||
| Return on equity (ROE) | 469.1% | 384.9% | 260.9% | 200.9% | 209.1% | 324.9% | 627.0% | — | — | — |
| Return on invested capital (ROIC) | 31.7% | 40.1% | 32.6% | 31.4% | 37.9% | 26.9% | 27.8% | 51.1% | 47.5% | 50.9% |
| Return on assets (ROA) | 13.2% | 17.8% | 14.3% | 11.6% | 14.0% | 17.4% | 17.4% | 19.3% | 16.3% | 20.3% |
| Return on tangible assets | 18.3% | 26.2% | 20.7% | 17.1% | 23.3% | 29.3% | 26.7% | 30.0% | 22.2% | 28.0% |
| Free cash flow margin | 17.8% | 17.6% | 15.6% | 10.4% | 15.8% | 20.1% | 17.8% | 16.9% | 16.2% | 16.8% |
| Income quality (OCF / net income) | 1.97 | 1.42 | 1.63 | 1.43 | 1.54 | 1.38 | 1.32 | 1.27 | 1.51 | 1.29 |
| Financial health | ||||||||||
| Total debt | $8.55B | $8.51B | $9.06B | $9.27B | $7.43B | $7.74B | $15.18B | $6.37B | $6.58B | $6.53B |
| Cash & short-term investments | $1.29B | $1.26B | $966.0M | $775.0M | $832.0M | $888.0M | $883.0M | $726.0M | $1.53B | $1.31B |
| Net debt | $7.27B | $7.26B | $8.10B | $8.50B | $6.60B | $6.85B | $14.30B | $5.64B | $5.04B | $5.22B |
| Debt / equity | 23.44 | 15.65 | 9.47 | 11.50 | 7.65 | 7.03 | 27.20 | 32.31 | 27.07 | 384.29 |
| Debt / assets | 0.52 | 0.53 | 0.55 | 0.59 | 0.49 | 0.49 | 1.01 | 0.52 | 0.52 | 0.54 |
| Net debt / EBITDA | 1.49 | 1.50 | 1.91 | 2.52 | 1.76 | 1.58 | 3.56 | 1.35 | 1.23 | 1.21 |
| Current ratio | 1.00 | 0.92 | 1.11 | 1.28 | 1.10 | 1.05 | 0.37 | 1.14 | 1.36 | 1.31 |
| Quick ratio | 0.64 | 0.58 | 0.71 | 0.76 | 0.68 | 0.64 | 0.24 | 0.76 | 1.00 | 0.96 |
| Interest coverage | 12.4 | 15.0 | 14.4 | 21.5 | 33.2 | 24.4 | 19.6 | 19.9 | 26.2 | 26.6 |
| Working capital | −$27.0M | −$442.0M | $538.0M | $1.11B | $397.0M | $201.0M | −$7.19B | $452.0M | $1.23B | $1.03B |
| Invested capital | $7.63B | $7.80B | $9.05B | $9.30B | $7.57B | $7.95B | $14.86B | $5.84B | $5.29B | $5.24B |
| Tangible asset value | −$4.29B | −$4.48B | −$4.34B | −$4.47B | −$4.78B | −$5.62B | −$5.62B | −$3.97B | −$3.32B | −$3.40B |
| Net current asset value | −$10.26B | −$10.19B | −$10.16B | −$9.81B | −$9.67B | −$10.48B | −$10.30B | −$8.17B | −$7.79B | −$7.77B |
| Graham number | $5.16 | $7.23 | $8.49 | $6.78 | $8.11 | $9.51 | $6.33 | $3.74 | $3.75 | $1.08 |
| Graham net-net per share | −$15.29 | −$14.73 | −$14.85 | −$14.29 | −$13.46 | −$14.14 | −$13.72 | −$10.95 | −$10.34 | −$10.18 |
| Capital allocation | ||||||||||
| Dividends paid | $1.82B | $1.79B | $1.75B | $1.69B | $1.68B | $1.65B | $1.61B | $1.59B | $1.53B | $1.51B |
| Share buybacks (net) | $1.21B | $1.74B | $1.13B | $1.31B | $1.32B | $1.48B | $1.20B | $1.24B | $1.40B | $1.33B |
| Dividend payout ratio | 85.5% | 61.9% | 76.0% | 94.7% | 77.5% | 61.4% | 68.2% | 66.3% | 75.5% | 61.8% |
| Dividends + buybacks / free cash flow | 83.5% | 99.5% | 94.6% | 161.2% | 108.7% | 94.6% | 100.6% | 108.0% | 117.1% | 111.6% |
| Capex / revenue | 2.8% | 2.8% | 3.6% | 3.9% | 3.3% | 2.5% | 2.1% | 2.8% | 3.6% | 3.9% |
| Capex / operating cash flow | 13.4% | 13.7% | 18.8% | 27.2% | 17.1% | 11.0% | 10.7% | 14.3% | 18.1% | 18.9% |
| Capex / depreciation | 0.90 | 0.93 | 1.24 | 1.28 | 1.02 | 0.76 | 0.65 | 0.85 | 1.16 | 1.34 |
| Stock-based compensation / revenue | 0.8% | 0.7% | 0.6% | 0.7% | 0.8% | 0.6% | 0.6% | 0.7% | 0.8% | 0.8% |
| R&D / revenue | 1.8% | 1.8% | 1.8% | 1.8% | 1.8% | 1.8% | 1.8% | 1.8% | 1.8% | 1.9% |
| SG&A / revenue | 38.7% | 25.3% | 25.0% | 25.4% | 25.3% | 24.7% | 24.7% | 24.7% | 24.8% | 24.6% |
| Efficiency | ||||||||||
| Days sales outstanding | 28.6 | 28.2 | 29.0 | 28.5 | 26.8 | 30.0 | 33.0 | 33.8 | 34.1 | 34.1 |
| Days of inventory on hand | 90.2 | 89.5 | 89.1 | 87.9 | 86.2 | 85.8 | 75.4 | 71.2 | 71.2 | 70.8 |
| Days payables outstanding | 87.4 | 80.0 | 72.3 | 70.7 | 73.5 | 73.4 | 69.9 | 70.1 | 69.5 | 67.2 |
| Cash conversion cycle (days) | 31.4 | 37.8 | 45.9 | 45.6 | 39.5 | 42.3 | 38.5 | 34.9 | 35.8 | 37.6 |
| Receivables turnover | 12.75 | 12.94 | 12.59 | 12.83 | 13.60 | 12.18 | 11.05 | 10.79 | 10.69 | 10.71 |
| Payables turnover | 4.18 | 4.56 | 5.05 | 5.16 | 4.96 | 4.97 | 5.22 | 5.21 | 5.25 | 5.43 |
| Inventory turnover | 4.05 | 4.08 | 4.09 | 4.15 | 4.24 | 4.26 | 4.84 | 5.13 | 5.13 | 5.16 |
| Asset turnover | 1.26 | 1.24 | 1.21 | 1.17 | 1.13 | 1.06 | 1.15 | 1.25 | 1.25 | 1.26 |
| Average receivables | $1.60B | $1.55B | $1.54B | $1.40B | $1.28B | $1.35B | $1.42B | $1.44B | $1.45B | $1.42B |
| Average payables | $1.95B | $1.75B | $1.62B | $1.51B | $1.44B | $1.31B | $1.23B | $1.22B | $1.17B | $1.12B |
| Average inventory | $2.01B | $1.96B | $2.00B | $1.88B | $1.68B | $1.54B | $1.32B | $1.24B | $1.20B | $1.18B |
| Intangibles / total assets | 28.5% | 31.3% | 32.3% | 33.5% | 38.2% | 42.2% | 41.1% | 34.3% | 28.1% | 28.2% |
Computed from CL's annual financial statements (latest annual report filed February 23, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
CL valuation and financial ratios
At the end of fiscal 2025 (December 31, 2025), Colgate-Palmolive traded at 30.1 times earnings, against a 10-year median of 28.0. Based on the latest twelve months, the trailing P/E is 37.1 and the forward P/E is 21.0. Colgate-Palmolive earned a return on equity of 469.1% and a return on invested capital of 31.7% in fiscal 2025. It ended the year with $8.6 billion of debt and $1.3 billion in cash and short-term investments, net debt of $7.3 billion. It returned $3.0 billion to shareholders: $1.8 billion in dividends and $1.2 billion in share buybacks, 83% of free cash flow. The share count fell 9.7% from 898.4M to 811.1M over 9 years.
See the CL income statement, the CL chart for price history, or the CL stock overview for the latest quote and news.
CL key metrics FAQ
What is Colgate-Palmolive's P/E ratio?
Colgate-Palmolive's trailing P/E ratio is 37.1 based on the last twelve months of earnings (as of October 18, 2026), and its forward P/E is 21.0. At the end of fiscal 2025 it was 30.1, compared with a 10-year median of 28.0.
What is Colgate-Palmolive's EV/EBITDA?
Colgate-Palmolive's enterprise value was 14.7 times EBITDA at the end of fiscal 2025 (enterprise value $71.4 billion, EBITDA $4.9 billion); the current EV/EBITDA is 19.5.
What is Colgate-Palmolive's return on equity?
Colgate-Palmolive's return on equity (ROE) was 469.1% in fiscal 2025: net income of $2.1 billion on average shareholders' equity of $454.5 million. ROE is high partly because years of buybacks have reduced equity on the balance sheet.
What is Colgate-Palmolive's ROIC?
Colgate-Palmolive's return on invested capital was 31.7% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does Colgate-Palmolive have?
Colgate-Palmolive had total debt of $8.6 billion at the end of fiscal 2025, a debt-to-equity ratio of 23.44 and $7.3 billion of net debt (1.49 times EBITDA).
What is Colgate-Palmolive's dividend yield?
Colgate-Palmolive's forward dividend yield is 2.25%. Colgate-Palmolive paid $1.8 billion in dividends in fiscal 2025 ($2.25 per share), a payout ratio of 85.5%.
Does Colgate-Palmolive buy back its shares?
Yes. Colgate-Palmolive spent $1.2 billion on net share repurchases in fiscal 2025 Shares outstanding changed −1.4% over the year, to 811.1M..
What is Colgate-Palmolive's free cash flow yield?
Colgate-Palmolive generated $3.6 billion of free cash flow in fiscal 2025, a free cash flow yield of 5.7% on its market value at year-end ($64.1 billion).
What is Colgate-Palmolive's current ratio?
Colgate-Palmolive's current ratio was 1.00 at the end of fiscal 2025: current assets were 1.00 times current liabilities.